Floseal®

DRUG4 trials

Sponsors

University of Sao Paulo General Hospital, Chang Gung Memorial Hospital, DALIM TISSEN Co., Ltd.

Conditions

HemostasisIntraoperative BleedingKnee OsteoarthritisOsteoarthritis, KneeSpinal InjurySpinal StenosisSpinal SurgerySpinal Tumor

Phase 4

Comparison of Floseal® and Tranexamic Acid on Bleeding Control After Total Knee Arthroplasty

University of Sao Paulo General HospitalKnee Osteoarthritis

Start: 2014-02-28End: 2015-05-31Target: 45Updated: 2014-06-02

Topical Tranexamic Acid and Floseal® in Total Knee Arthroplasty

Chang Gung Memorial HospitalOsteoarthritis, Knee

Start: 2016-09-30End: 2017-08-31Target: 90Updated: 2016-08-12

Combined Topical Tranexamic Acid With Floseal® in Total Knee Arthroplasty

CompletedNCT03328832

Chang Gung Memorial HospitalOsteoarthritis, Knee

Start: 2017-09-12End: 2018-12-30Updated: 2021-08-10

Unknown Phase

Study of Collagen-Based Thrombin Hemostat for the Control of Bleeding in Spinal Surgery

CompletedNCT07354178

DALIM TISSEN Co., Ltd.Hemostasis, Intraoperative Bleeding, Spinal Injury +3

Start: 2024-10-22End: 2025-08-18Updated: 2026-01-21

Related Papers

Comparison of Effects of a Thrombin‐Based Hemostatic Agent and Topical Tranexamic Acid on Blood Loss in Patients with Preexisting Thromboembolic Risk Undergoing a Minimally Invasive Total Knee Arthroplasty. A Prospective Randomized Controlled Trial

BioMed Research International2021-01-0122 citations

Comparison of Floseal® and Tranexamic Acid for Bleeding Control after Total Knee Arthroplasty: a Prospective Randomized Study.

2019-11-2515 citations